Skip to content
Companies

ARC Medical

Liquid barrier that prevents surgical adhesions

Raised to date

$1.7M

across 7 Form D filings

Investors
8
Last filed
Oct 9, 2026

About

ARC Medical Inc. is a clinical-stage therapeutics company dedicated to developing innovative solutions to prevent surgical adhesions, a prevalent complication following various surgical procedures. With a commitment to improving patient outcomes, the company focuses on clinical advancements that mitigate the risks associated with adhesive formations post-surgery.

The company's proprietary liquid medical devices create temporary barrier films that significantly reduce the formation of surgical adhesions, thereby enhancing recovery and reducing post-operative complications.

Funding

No target, first sold Oct 2024$1.5M sold20252026
Now
  • EquityFiled Oct 9, 2026Form D/A
    $167K/ $167K
  • EquityFiled Nov 10, 2025Form D/A
    $1.5M/ no target
  • EquityFiled Nov 6, 2025Form D/A
    $1.4M/ $1.4M
  • EquityFiled Oct 15, 2025Form D/A
    $1M/ $1M
  • EquityFiled Aug 7, 2025Form D/A
    $901K/ $901K
  • EquityFiled May 20, 2025Form D/A
    $825K/ $825K
  • EquityFiled Mar 21, 2025Form D/A
    $589K/ $589K

Product

IPCOAT™

Surgical Adhesion Prevention

IPCOAT™ is an innovative liquid medical device utilized during gynecological and abdominal surgeries. It flows across the surgical site to form a protective barrier film over tissues, proactively preventing the occurrence of adhesions that can emerge post-surgery.

  • Formulates a temporary adhesion barrier
  • Compatible with open and laparoscopic procedures
  • Designed for various surgical specialties

Built for

Hospitals and healthcare providers performing surgical procedures

People on file